International cooperation to address and counter the world drug problem A/RES/74/178 of internationally recognized standards, such as the International Standards on Drug Use Prevention, and the exchange of best practices, and to formulate effective drug use prevention strategies and programmes in cooperation with the United Nations Office on Drugs and Crime, the World Health Organization and other relevant United Nations entities; 24. Encourages Member States, in their promotion and improvement of the systematic collection of information and gathering of evidence, to gather scientific data on any damage to health that may be caused by consuming drugs in vaporized form, and to take appropriate steps to exchange best practices and formulate effective drug use prevention strategies and programmes, with a particular focus on children and youth; 25. Invites Member States to provide the United Nations Office on Drugs and Crime with information on best practices and programmes recently implemented, consistent with the three international drug control conventions, in order to assess recent developments and current and future challenges; 26. Recognizes drug dependence as a complex, multifactorial health disorder characterized by a chronic and relapsing nature, with social causes and consequences, that can be prevented and treated through, inter alia, effective scientific evidencebased drug treatment, care and rehabilitation programmes, including community based programmes, and also recognizes the need to strengthen capacity for aftercare for and the rehabilitation, recovery and social reintegra tion of individuals with substance use disorders, including, as appropriate, through assistance for effective reintegration into the labour market and other support services; 27. Encourages Member States to promote the prevention and treatment of drug use disorders, using scientific evidence-based practices, such as those outlined in the International Standards for the Treatment of Drug Use Disorders, that reflect respect for human rights and dignity, including the right to enjoy the highest attainable standard of physical and mental health and well-being, promoting, as appropriate, within national and regional contexts, non-stigmatizing attitudes in the development and implementation of scientific evidence-based policies; 28. Also encourages Member States to promote the inclusion in national drug policies, in accordance with national legislation and as appropriate, of elements for the prevention and treatment of drug overdose, in particular opioid overdose, including the use of opioid receptor antagonists, such as naloxone, to reduce drugrelated mortality; 29. Invites Member States to promote cooperation with and technical assistance to the States most affected by the world drug problem in developing and implementing comprehensive and integrated policies to address, where appropriate, the impact of illicit drug trafficking on increasing drug use in such States, including by reinforcing national programmes aimed at prevention, early intervention, treatment, care, rehabilitation and social reintegration; 30. Encourages the United Nations Office on Drugs and Crime and the International Narcotics Control Board to continue to strengthen cooperation with the World Health Organization and other competent United Nations entities, within their respective mandates, as part of a comprehensive, integrated and balanced approach to strengthening health and social welfare measures in addressing the world drug problem, including through effective prevention, early intervention, treatment, care, recovery, rehabilitation and social reintegration, in cooperation, as appropriate, with civil society and the scientific community, and to keep the Commission on Narcotic Drugs appropriately updated; 19-22335 9/23

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents